1) Do the current available data allow to understand the threat level of coronarivus 2019-nCoV
in terms of both lethality and diffusion speed, and about the possible evolution scenarios of the
disease?

2) What exactly we know about its modes of transmission, especially from people who do not
yet have the symptoms?

3) Are the genetic sequences provided by China enough to start working on a vaccine?

What are the technical times to develop a working vaccine in terms of scientific research, and
what are the approx times for the necessary legal certifications, and for industrial production and
distribution?

4) 2019-nCov is the third Coronavirus aggressive for humans that has appeared in the East in the
last 20 years and in 2009 the virus responsible for the flu pandemic too did come from China:
what sort of preventive measures could be practicable to reduce the risk of repetition of these
events?

Thank you so much for your time your attention!

Kindest Regards

Enrica Battifoglia
Science and Technology Head Editor

ANSA News Agency

if contenuto di questa e-mail é rivolto unicamente alle persane alle quali é indirizzato; fe relative informazioni sono da
considerarsi strettamente riservate e tutelate ai sensi del Regolamento UE 2016/679 {GDPR} per la Protezione dei Dati
Personali, nonché del D. Lgs. n. 196/2003 e successive medifiche. Sono vietati la riproduzione, fa diffusione e l’uso di questa e-
mail in mancanze di autorizzazione del destinatario. In caso di ricezione della presente e-mail per errore, si prega di non

NIH-002283
